Initiation of buprenorphine during incarceration and retention in treatment upon release
Abstract We report here on a feasibility study of initiating buprenorphine/naloxone prior to release from incarceration and linking participants to community treatment providers upon release. The study consisted of a small number of Rhode Island (RI) prisoners ( N = 44) diagnosed with opioid depende...
Gespeichert in:
| Veröffentlicht in: | Journal of substance abuse treatment 2013-08, Vol.45 (2), p.222-226 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 226 |
|---|---|
| container_issue | 2 |
| container_start_page | 222 |
| container_title | Journal of substance abuse treatment |
| container_volume | 45 |
| creator | Zaller, Nickolas, Ph.D McKenzie, Michelle, M.P.H Friedmann, Peter D., M.D., M.P.H Green, Traci C., Ph.D McGowan, Samuel, B.A Rich, Josiah D., M.D., M.P.H |
| description | Abstract We report here on a feasibility study of initiating buprenorphine/naloxone prior to release from incarceration and linking participants to community treatment providers upon release. The study consisted of a small number of Rhode Island (RI) prisoners ( N = 44) diagnosed with opioid dependence. The study design is a single arm, open-label pilot study with a 6-month follow up interview conducted in the community. However, a natural experiment arose during the study comparing pre-release initiation of buprenorphone/naloxone to initiation post-release. Time to post-release prescriber appointment (mean days) for initiation of treatment outside Rhode Island Department of Corrections (RIDOC) versus inside RIDOC was 8.8 and 3.9, respectively ( p = .1). Median post release treatment duration (weeks) for outside RIDOC versus inside RIDOC was 9 and 24, respectively ( p = .007). We conclude that initiating buprenorphine/naloxone prior to release from incarceration may increase engagement and retention in community-based treatment. |
| doi_str_mv | 10.1016/j.jsat.2013.02.005 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3690138</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0740547213000573</els_id><sourcerecordid>3007293621</sourcerecordid><originalsourceid>FETCH-LOGICAL-c535t-21ee8087e081a6e59568d6b909b363a277c159b3792c9c25d5efc1f3f7e21abc3</originalsourceid><addsrcrecordid>eNp9Uk1v1DAUtBCILoU_wAFFQhyTPtvrOJFQJVTxUalSDwWJm-U4L61D1g62U6n_HoddWsqBk79m5o3fPEJeU6go0PpkrMaoU8WA8gpYBSCekA1tJC_rbcOfkg3ILZRiK9kReRHjCACMQfOcHDEutpQD35Dv584mq5P1rvBD0S1zQOfDfGMdFv0SrLsurDM6GAx7lHZ9ETCh-32yrkgBddrlc7HM-SbghDriS_Js0FPEV4f1mHz79PHr2Zfy4vLz-dmHi9IILlLJKGIDjURoqK5RtKJu-rproe14zTWT0lCR97JlpjVM9AIHQwc-SGRUd4Yfk9O97rx0O-xN9hH0pOZgdzrcKa-tevzi7I269reK121uXJMF3h4Egv-5YExq9Etw2bOiXDIqZNvKjGJ7lAk-xoDDfQUKak1DjWpNQ61pKGAqp5FJb_72dk_50_4MeHcA6Gj0NATtjI0POCkAJFuF3u9xmDt5azGoaCw6g70NaJLqvf2_j9N_6GayzuaKP_AO48N_VcwEdbXOzTo22WOmS85_AbAZvx0</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1372157997</pqid></control><display><type>article</type><title>Initiation of buprenorphine during incarceration and retention in treatment upon release</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><source>Applied Social Sciences Index & Abstracts (ASSIA)</source><creator>Zaller, Nickolas, Ph.D ; McKenzie, Michelle, M.P.H ; Friedmann, Peter D., M.D., M.P.H ; Green, Traci C., Ph.D ; McGowan, Samuel, B.A ; Rich, Josiah D., M.D., M.P.H</creator><creatorcontrib>Zaller, Nickolas, Ph.D ; McKenzie, Michelle, M.P.H ; Friedmann, Peter D., M.D., M.P.H ; Green, Traci C., Ph.D ; McGowan, Samuel, B.A ; Rich, Josiah D., M.D., M.P.H</creatorcontrib><description>Abstract We report here on a feasibility study of initiating buprenorphine/naloxone prior to release from incarceration and linking participants to community treatment providers upon release. The study consisted of a small number of Rhode Island (RI) prisoners ( N = 44) diagnosed with opioid dependence. The study design is a single arm, open-label pilot study with a 6-month follow up interview conducted in the community. However, a natural experiment arose during the study comparing pre-release initiation of buprenorphone/naloxone to initiation post-release. Time to post-release prescriber appointment (mean days) for initiation of treatment outside Rhode Island Department of Corrections (RIDOC) versus inside RIDOC was 8.8 and 3.9, respectively ( p = .1). Median post release treatment duration (weeks) for outside RIDOC versus inside RIDOC was 9 and 24, respectively ( p = .007). We conclude that initiating buprenorphine/naloxone prior to release from incarceration may increase engagement and retention in community-based treatment.</description><identifier>ISSN: 0740-5472</identifier><identifier>EISSN: 1873-6483</identifier><identifier>DOI: 10.1016/j.jsat.2013.02.005</identifier><identifier>PMID: 23541303</identifier><identifier>CODEN: JSATEG</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Addiction ; Addictive behaviors ; Adult ; Adult and adolescent clinical studies ; Biological and medical sciences ; Buprenorphine - administration & dosage ; Buprenorphine, Naloxone Drug Combination ; Buprenorphine/naloxone ; Community Health Services - methods ; Comparative analysis ; Desintoxication. Drug withdrawal ; Drug addiction ; Feasibility Studies ; Female ; Follow-Up Studies ; HIV ; Humans ; Imprisonment ; Incarceration ; Male ; Medical sciences ; Middle Aged ; Miscellaneous ; Naloxone - administration & dosage ; Opiate Substitution Treatment - methods ; Opiates ; Opioid-Related Disorders - rehabilitation ; Patient Compliance ; Pilot Projects ; Prisoners ; Psychiatry ; Psychology. Psychoanalysis. Psychiatry ; Psychopathology. Psychiatry ; Public health. Hygiene ; Public health. Hygiene-occupational medicine ; Rhode Island ; Substance abuse treatment ; Time Factors ; Treatments</subject><ispartof>Journal of substance abuse treatment, 2013-08, Vol.45 (2), p.222-226</ispartof><rights>Elsevier Inc.</rights><rights>2013 Elsevier Inc.</rights><rights>2015 INIST-CNRS</rights><rights>Copyright © 2013 Elsevier Inc. All rights reserved.</rights><rights>Copyright Pergamon Press Inc. Aug 2013</rights><rights>2013 Elsevier Inc. All rights reserved. 2013</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c535t-21ee8087e081a6e59568d6b909b363a277c159b3792c9c25d5efc1f3f7e21abc3</citedby><cites>FETCH-LOGICAL-c535t-21ee8087e081a6e59568d6b909b363a277c159b3792c9c25d5efc1f3f7e21abc3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0740547213000573$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,776,780,881,3536,27903,27904,30978,65309</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=27500725$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23541303$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zaller, Nickolas, Ph.D</creatorcontrib><creatorcontrib>McKenzie, Michelle, M.P.H</creatorcontrib><creatorcontrib>Friedmann, Peter D., M.D., M.P.H</creatorcontrib><creatorcontrib>Green, Traci C., Ph.D</creatorcontrib><creatorcontrib>McGowan, Samuel, B.A</creatorcontrib><creatorcontrib>Rich, Josiah D., M.D., M.P.H</creatorcontrib><title>Initiation of buprenorphine during incarceration and retention in treatment upon release</title><title>Journal of substance abuse treatment</title><addtitle>J Subst Abuse Treat</addtitle><description>Abstract We report here on a feasibility study of initiating buprenorphine/naloxone prior to release from incarceration and linking participants to community treatment providers upon release. The study consisted of a small number of Rhode Island (RI) prisoners ( N = 44) diagnosed with opioid dependence. The study design is a single arm, open-label pilot study with a 6-month follow up interview conducted in the community. However, a natural experiment arose during the study comparing pre-release initiation of buprenorphone/naloxone to initiation post-release. Time to post-release prescriber appointment (mean days) for initiation of treatment outside Rhode Island Department of Corrections (RIDOC) versus inside RIDOC was 8.8 and 3.9, respectively ( p = .1). Median post release treatment duration (weeks) for outside RIDOC versus inside RIDOC was 9 and 24, respectively ( p = .007). We conclude that initiating buprenorphine/naloxone prior to release from incarceration may increase engagement and retention in community-based treatment.</description><subject>Addiction</subject><subject>Addictive behaviors</subject><subject>Adult</subject><subject>Adult and adolescent clinical studies</subject><subject>Biological and medical sciences</subject><subject>Buprenorphine - administration & dosage</subject><subject>Buprenorphine, Naloxone Drug Combination</subject><subject>Buprenorphine/naloxone</subject><subject>Community Health Services - methods</subject><subject>Comparative analysis</subject><subject>Desintoxication. Drug withdrawal</subject><subject>Drug addiction</subject><subject>Feasibility Studies</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>HIV</subject><subject>Humans</subject><subject>Imprisonment</subject><subject>Incarceration</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Miscellaneous</subject><subject>Naloxone - administration & dosage</subject><subject>Opiate Substitution Treatment - methods</subject><subject>Opiates</subject><subject>Opioid-Related Disorders - rehabilitation</subject><subject>Patient Compliance</subject><subject>Pilot Projects</subject><subject>Prisoners</subject><subject>Psychiatry</subject><subject>Psychology. Psychoanalysis. Psychiatry</subject><subject>Psychopathology. Psychiatry</subject><subject>Public health. Hygiene</subject><subject>Public health. Hygiene-occupational medicine</subject><subject>Rhode Island</subject><subject>Substance abuse treatment</subject><subject>Time Factors</subject><subject>Treatments</subject><issn>0740-5472</issn><issn>1873-6483</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>7QJ</sourceid><recordid>eNp9Uk1v1DAUtBCILoU_wAFFQhyTPtvrOJFQJVTxUalSDwWJm-U4L61D1g62U6n_HoddWsqBk79m5o3fPEJeU6go0PpkrMaoU8WA8gpYBSCekA1tJC_rbcOfkg3ILZRiK9kReRHjCACMQfOcHDEutpQD35Dv584mq5P1rvBD0S1zQOfDfGMdFv0SrLsurDM6GAx7lHZ9ETCh-32yrkgBddrlc7HM-SbghDriS_Js0FPEV4f1mHz79PHr2Zfy4vLz-dmHi9IILlLJKGIDjURoqK5RtKJu-rproe14zTWT0lCR97JlpjVM9AIHQwc-SGRUd4Yfk9O97rx0O-xN9hH0pOZgdzrcKa-tevzi7I269reK121uXJMF3h4Egv-5YExq9Etw2bOiXDIqZNvKjGJ7lAk-xoDDfQUKak1DjWpNQ61pKGAqp5FJb_72dk_50_4MeHcA6Gj0NATtjI0POCkAJFuF3u9xmDt5azGoaCw6g70NaJLqvf2_j9N_6GayzuaKP_AO48N_VcwEdbXOzTo22WOmS85_AbAZvx0</recordid><startdate>20130801</startdate><enddate>20130801</enddate><creator>Zaller, Nickolas, Ph.D</creator><creator>McKenzie, Michelle, M.P.H</creator><creator>Friedmann, Peter D., M.D., M.P.H</creator><creator>Green, Traci C., Ph.D</creator><creator>McGowan, Samuel, B.A</creator><creator>Rich, Josiah D., M.D., M.P.H</creator><general>Elsevier Inc</general><general>Elsevier</general><general>Elsevier Limited</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QJ</scope><scope>K7.</scope><scope>K9.</scope><scope>5PM</scope></search><sort><creationdate>20130801</creationdate><title>Initiation of buprenorphine during incarceration and retention in treatment upon release</title><author>Zaller, Nickolas, Ph.D ; McKenzie, Michelle, M.P.H ; Friedmann, Peter D., M.D., M.P.H ; Green, Traci C., Ph.D ; McGowan, Samuel, B.A ; Rich, Josiah D., M.D., M.P.H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c535t-21ee8087e081a6e59568d6b909b363a277c159b3792c9c25d5efc1f3f7e21abc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Addiction</topic><topic>Addictive behaviors</topic><topic>Adult</topic><topic>Adult and adolescent clinical studies</topic><topic>Biological and medical sciences</topic><topic>Buprenorphine - administration & dosage</topic><topic>Buprenorphine, Naloxone Drug Combination</topic><topic>Buprenorphine/naloxone</topic><topic>Community Health Services - methods</topic><topic>Comparative analysis</topic><topic>Desintoxication. Drug withdrawal</topic><topic>Drug addiction</topic><topic>Feasibility Studies</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>HIV</topic><topic>Humans</topic><topic>Imprisonment</topic><topic>Incarceration</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Miscellaneous</topic><topic>Naloxone - administration & dosage</topic><topic>Opiate Substitution Treatment - methods</topic><topic>Opiates</topic><topic>Opioid-Related Disorders - rehabilitation</topic><topic>Patient Compliance</topic><topic>Pilot Projects</topic><topic>Prisoners</topic><topic>Psychiatry</topic><topic>Psychology. Psychoanalysis. Psychiatry</topic><topic>Psychopathology. Psychiatry</topic><topic>Public health. Hygiene</topic><topic>Public health. Hygiene-occupational medicine</topic><topic>Rhode Island</topic><topic>Substance abuse treatment</topic><topic>Time Factors</topic><topic>Treatments</topic><toplevel>online_resources</toplevel><creatorcontrib>Zaller, Nickolas, Ph.D</creatorcontrib><creatorcontrib>McKenzie, Michelle, M.P.H</creatorcontrib><creatorcontrib>Friedmann, Peter D., M.D., M.P.H</creatorcontrib><creatorcontrib>Green, Traci C., Ph.D</creatorcontrib><creatorcontrib>McGowan, Samuel, B.A</creatorcontrib><creatorcontrib>Rich, Josiah D., M.D., M.P.H</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Applied Social Sciences Index & Abstracts (ASSIA)</collection><collection>ProQuest Criminal Justice (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of substance abuse treatment</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zaller, Nickolas, Ph.D</au><au>McKenzie, Michelle, M.P.H</au><au>Friedmann, Peter D., M.D., M.P.H</au><au>Green, Traci C., Ph.D</au><au>McGowan, Samuel, B.A</au><au>Rich, Josiah D., M.D., M.P.H</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Initiation of buprenorphine during incarceration and retention in treatment upon release</atitle><jtitle>Journal of substance abuse treatment</jtitle><addtitle>J Subst Abuse Treat</addtitle><date>2013-08-01</date><risdate>2013</risdate><volume>45</volume><issue>2</issue><spage>222</spage><epage>226</epage><pages>222-226</pages><issn>0740-5472</issn><eissn>1873-6483</eissn><coden>JSATEG</coden><abstract>Abstract We report here on a feasibility study of initiating buprenorphine/naloxone prior to release from incarceration and linking participants to community treatment providers upon release. The study consisted of a small number of Rhode Island (RI) prisoners ( N = 44) diagnosed with opioid dependence. The study design is a single arm, open-label pilot study with a 6-month follow up interview conducted in the community. However, a natural experiment arose during the study comparing pre-release initiation of buprenorphone/naloxone to initiation post-release. Time to post-release prescriber appointment (mean days) for initiation of treatment outside Rhode Island Department of Corrections (RIDOC) versus inside RIDOC was 8.8 and 3.9, respectively ( p = .1). Median post release treatment duration (weeks) for outside RIDOC versus inside RIDOC was 9 and 24, respectively ( p = .007). We conclude that initiating buprenorphine/naloxone prior to release from incarceration may increase engagement and retention in community-based treatment.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>23541303</pmid><doi>10.1016/j.jsat.2013.02.005</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0740-5472 |
| ispartof | Journal of substance abuse treatment, 2013-08, Vol.45 (2), p.222-226 |
| issn | 0740-5472 1873-6483 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3690138 |
| source | MEDLINE; Elsevier ScienceDirect Journals; Applied Social Sciences Index & Abstracts (ASSIA) |
| subjects | Addiction Addictive behaviors Adult Adult and adolescent clinical studies Biological and medical sciences Buprenorphine - administration & dosage Buprenorphine, Naloxone Drug Combination Buprenorphine/naloxone Community Health Services - methods Comparative analysis Desintoxication. Drug withdrawal Drug addiction Feasibility Studies Female Follow-Up Studies HIV Humans Imprisonment Incarceration Male Medical sciences Middle Aged Miscellaneous Naloxone - administration & dosage Opiate Substitution Treatment - methods Opiates Opioid-Related Disorders - rehabilitation Patient Compliance Pilot Projects Prisoners Psychiatry Psychology. Psychoanalysis. Psychiatry Psychopathology. Psychiatry Public health. Hygiene Public health. Hygiene-occupational medicine Rhode Island Substance abuse treatment Time Factors Treatments |
| title | Initiation of buprenorphine during incarceration and retention in treatment upon release |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T08%3A04%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Initiation%20of%20buprenorphine%20during%20incarceration%20and%20retention%20in%20treatment%20upon%20release&rft.jtitle=Journal%20of%20substance%20abuse%20treatment&rft.au=Zaller,%20Nickolas,%20Ph.D&rft.date=2013-08-01&rft.volume=45&rft.issue=2&rft.spage=222&rft.epage=226&rft.pages=222-226&rft.issn=0740-5472&rft.eissn=1873-6483&rft.coden=JSATEG&rft_id=info:doi/10.1016/j.jsat.2013.02.005&rft_dat=%3Cproquest_pubme%3E3007293621%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1372157997&rft_id=info:pmid/23541303&rft_els_id=S0740547213000573&rfr_iscdi=true |